Literature DB >> 33585152

Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology.

Ismail Pasha1, Rohini S Kavalapure2, Sharad Chand3, Shailendra Gurav4, Pukar Khanal5, Taaza Duyu5, B M Patil5, Yadu Nandan Dey6.   

Abstract

The majority of the bioactives under investigation were predicted to target TNF receptor-associated factor 5 in the Janus kinase/signal transducers and activators of the transcription pathway. Similarly, druglikeness prediction identified vitexilactone to possess the highest druglikeness score, i.e., 0.88. Furthermore, proteins targeted in the Janus kinase/signal transducers and activators of transcription pathway were also predicted to regulate multiple pathways, i.e., ErbB, AGE-RAGE, NF-kappa B, Measles, insulin, mTOR, chemokine, Ras, and pathways associated with infectious and non-infectious pathogenesis, where the immune system is compromised. Similarly, the docking study identified sesaminol 2-O-β-D-gentiobioside to possess the highest binding affinity with 3CLpro, PLpro, and spike proteins. Furthermore, phylogeny comparison identified the common protein domains with other stains of microbes like murine hepatitis virus strain A59, avian infectious bronchitis virus, and porcine epidemic diarrhea virus CV777. © King Abdulaziz City for Science and Technology 2021.

Entities:  

Keywords:  3CLpro; Anti-viral; COVID-19; Coronavirus; JAK-STAT pathway; PLpro; Spike protein

Year:  2021        PMID: 33585152      PMCID: PMC7869079          DOI: 10.1007/s13205-021-02664-4

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  31 in total

Review 1.  Modulation of CD4+ T Helper Cell Memory Responses in the Human Skin.

Authors:  Elisabetta Padovan
Journal:  Int Arch Allergy Immunol       Date:  2017-08-09       Impact factor: 2.749

2.  Lead- and drug-like compounds: the rule-of-five revolution.

Authors:  Christopher A Lipinski
Journal:  Drug Discov Today Technol       Date:  2004-12

3.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

4.  TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infection.

Authors:  Zachary J Kraus; Jodie S Haring; Gail A Bishop
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

5.  Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19.

Authors:  Pukar Khanal; Rupesh Chikhale; Yadu Nandan Dey; Ismail Pasha; Sharad Chand; Nilambari Gurav; Muniappan Ayyanar; B M Patil; Shailendra Gurav
Journal:  J Biomol Struct Dyn       Date:  2021-01-18       Impact factor: 5.235

6.  Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach.

Authors:  Rupesh V Chikhale; Shailendra S Gurav; Rajesh B Patil; Saurabh K Sinha; Satyendra K Prasad; Anshul Shakya; Sushant K Shrivastava; Nilambari S Gurav; Rupali S Prasad
Journal:  J Biomol Struct Dyn       Date:  2020-06-22

7.  An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets.

Authors:  Saurabh K Sinha; Anshul Shakya; Satyendra K Prasad; Shashikant Singh; Nilambari S Gurav; Rupali S Prasad; Shailendra S Gurav
Journal:  J Biomol Struct Dyn       Date:  2020-05-13

8.  Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis.

Authors:  Rupesh Chikhale; Saurabh K Sinha; Manish Wanjari; Nilambari S Gurav; Muniappan Ayyanar; Satyendra Prasad; Pukar Khanal; Yadu Nandan Dey; Rajesh B Patil; Shailendra S Gurav
Journal:  Mol Divers       Date:  2021-01-25       Impact factor: 3.364

9.  Anthraquinone Derivatives as an Immune Booster and their Therapeutic Option Against COVID-19.

Authors:  Pukar Khanal; B M Patil; Jagdish Chand; Yasmin Naaz
Journal:  Nat Prod Bioprospect       Date:  2020-08-08

Review 10.  Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus.

Authors:  J H Kuhn; W Li; H Choe; M Farzan
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

View more
  1 in total

1.  Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19.

Authors:  Liang Hong; Min He; Shaoping Li; Jing Zhao
Journal:  Chin Med       Date:  2022-07-07       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.